发明名称 |
Rapid Disperse Dosage Form Containing Levetiracetam |
摘要 |
A high dose rapidly dispersing three-dimensionally printed dosage form comprising a high dose of levetiracetam in a porous matrix that disperses in water within a period of less than about 15 seconds is disclosed. Also disclosed are methods of preparing the dosage form and of treating a condition, disease or disorder that is therapeutically responsive to levetiracetam. |
申请公布号 |
US2016220534(A1) |
申请公布日期 |
2016.08.04 |
申请号 |
US201615095785 |
申请日期 |
2016.04.11 |
申请人 |
APRECIA PHARMACEUTICALS COMPANY |
发明人 |
JACOB Jules;COYLE Norman;WEST Thomas G.;MONKHOUSE Donald C.;SURPRENANT Henry L.;JAIN Nemichand B. |
分类号 |
A61K31/4015;A61K9/70;A61K9/00 |
主分类号 |
A61K31/4015 |
代理机构 |
|
代理人 |
|
主权项 |
1) A method of treating a disease, condition or disorder that is therapeutically responsive to levetiracetam comprising orally administering one or more times daily to a subject in need thereof a rapidly dispersible solid dosage form comprising levetiracetam in a bound porous matrix that disperses in about 15 sec or less in a volume of about 15 ml or less of water or saliva, wherein the dosage form provides a Cmax within the ranges listed below when respective doses of levetiracetam are administered to the subject in the fasting state:DoseCmax(mg)(micrograms/ml)100013-53750 9-37500 5-202504-7 |
地址 |
Langhorne PA US |